Search Legislation

Commission Implementing Regulation (EU) 2020/1397Show full title

Commission Implementing Regulation (EU) 2020/1397 of 5 October 2020 concerning the renewal of the authorisation of L-isoleucine produced by Escherichia coli FERM ABP-10641 as a nutritional additive, its extension of use and the authorisation of L-isoleucine produced by Corynebacterium glutamicum KCCM 80189 as a feed additive for all animal species, and repealing Regulation (EU) No 348/2010 (Text with EEA relevance)

 Help about what version

What Version

 Help about advanced features

Advanced Features

 Help about UK-EU Regulation

Legislation originating from the EU

When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.

Close

This item of legislation originated from the EU

Legislation.gov.uk publishes the UK version. EUR-Lex publishes the EU version. The EU Exit Web Archive holds a snapshot of EUR-Lex’s version from IP completion day (31 December 2020 11.00 p.m.).

Changes to legislation:

This version of this Regulation was derived from EUR-Lex on IP completion day (31 December 2020 11:00 p.m.). It has not been amended by the UK since then. Find out more about legislation originating from the EU as published on legislation.gov.uk. Help about Changes to Legislation

Close

Changes to Legislation

Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.

ANNEXU.K.

a

Details of the analytical methods are available at the following address of the Reference Laboratory: https://ec.europa.eu/jrc/en/eurl/feed-additives/evaluation-reports

b

Commission Regulation (EC) No 152/2009 of 27 January 2009 laying down the methods of sampling and analysis for the official control of feed (OJ L 54, 26.2.2009, p. 1).

c

Exposure calculated based on the endotoxin level and the dusting potential of the additive according to the method used by EFSA (EFSA Journal 2020;18(2):6022); analytical method: European Pharmacopoeia 2.6.14. (bacterial endotoxins).

Identification number of the additiveName of the holder of authorisationAdditiveComposition, chemical formula, description, analytical method.Species or category of animalMaximum ageMinimum contentMaximum contentOther provisionsEnd of period of authorisation
mg/kg of complete feed with a moisture content of 12 %
Category: nutritional additives. Functional group: amino acids, their salts and analogues.
3c381-L-isoleucine

Additive composition

Powder with a minimum content of L-isoleucine of 93,4 % (on a dry matter basis)

All animal species---
1.

L-isoleucine may be placed on the market and used as an additive consisting of a preparation.

2.

In the directions for use of the additive and premixture, the storage conditions, the stability to heat treatment and in water shall be indicated.

3.

The additive may be used via water for drinking.

4.

Declaration to be made on the label of the additive and premixture:

  • ‘The supplementation with L-isoleucine, in particular via water for drinking, shall take into account all essential and conditionally essential amino acids in order to avoid imbalances.’

  • L-isoleucine content.

5.

The endotoxin content of the additive and its dusting potential shall ensure a maximal endotoxin exposure of 1 600 IU endotoxins/m3 air c.

6.

For users of the additive and premixture, feed business operators shall establish operational procedures and organisational measures to address potential risks by inhalation. Where those risks cannot be eliminated or reduced to a minimum by such procedures and measures, the additive and premixture shall be used with personal protective equipment.

26 October 2030

Characterisation of the active substance

L-isoleucine produced by fermentation with Escherichia coli FERM ABP-10641

IUPAC name: (2S,3S)-2-amino-3-methylpentanoic acid

Chemical formula: C6H13NO2

CAS number: 73-32-5

Analytical method a

For the identification of L-isoleucine in the feed additive:

  • Food Chemical Codex ‘L-isoleucine monograph’

For the quantification of isoleucine in the feed additive:

  • ion exchange chromatography coupled with post-column derivatisation and optical detection (IEC-VIS/FLD) or

  • ion exchange chromatography coupled with post-column derivatisation and photometric detection (IEC-VIS)

For the quantification of isoleucine in premixtures:

  • ion-exchange chromatography coupled with post-column derivatisation and optical detection (IEC-VIS/FLD) or

  • ion exchange chromatography coupled with post-column derivatisation and photometric detection (IEC-VIS) – Regulation (EC) No 152/2009b (Annex III, F)

For the quantification of isoleucine in compound feed and feed materials:

  • ion exchange chromatography coupled with post-column derivatisation and photometric detection (IEC-VIS) – Regulation (EC) No 152/2009 (Annex III, F)

For the quantification of isoleucine in water:

  • ion exchange chromatography coupled with post-column derivatisation and photometric detection (IEC-VIS)

3c383-L-isoleucine

Additive composition

Powder with a minimum content of L-isoleucine of 90 %

All animal species---
1.

L-isoleucine may be placed on the market and used as an additive consisting of a preparation.

2.

In the directions for use of the additive and premixture, the storage conditions, the stability to heat treatment and in water shall be indicated.

3.

The additive may be used via water for drinking.

4.

Declaration to be made on the label of the additive and premixture:

  • ‘The supplementation with L-isoleucine, in particular via water for drinking, shall take into account all essential and conditionally essential amino acids in order to avoid imbalances.’

  • L-isoleucine content.

26 October 2030

Characterisation of the active substance

L-isoleucine produced by fermentation with Corynebacterium glutamicum KCCM 80189

IUPAC name: (2S,3S)-2-amino-3-methylpentanoic acid

Chemical formula: C6H13NO2

CAS number: 73-32-5

Analytical method a

For the identification of L-isoleucine in the feed additive:

  • Food Chemical Codex ‘L-isoleucine monograph’

For the quantification of isoleucine in the feed additive:

  • ion exchange chromatography coupled with post-column derivatisation and optical detection (IEC-VIS/FLD) or

  • ion exchange chromatography coupled with post-column derivatisation and photometric detection (IEC-VIS)

For the quantification of isoleucine in premixtures:

  • ion-exchange chromatography coupled with post-column derivatisation and optical detection (IEC-VIS/FLD) or

  • ion exchange chromatography coupled with post-column derivatisation and photometric detection (IEC-VIS) – Regulation (EC) No 152/2009 (Annex III, F)

For the quantification of isoleucine in compound feed and feed materials:

  • ion exchange chromatography coupled with post-column derivatisation and photometric detection (IEC-VIS) – Regulation (EC) No 152/2009 (Annex III, F)

For the quantification of isoleucine in water:

  • ion exchange chromatography coupled with post-column derivatisation and photometric detection (IEC-VIS)

Category: Sensory additives. Functional group: Flavouring compounds
3c381-L-isoleucine

Additive composition

Powder with a minimum content of L-isoleucine of 93,4 % (on a dry matter basis)

All animal species--
1.

L-isoleucine may be placed on the market and used as an additive consisting of a preparation.

2.

The additive shall be incorporated into the feed in the form of a premixture.

3.

In the directions for use of the additive and premixture, the storage conditions and the stability to heat treatment shall be indicated.

4.

On the label of the additive the following shall be indicated: ‘Recommended maximum content of the active substance of complete feedingstuff with a moisture content of 12 %: 25 mg/kg.’

5.

The functional group, the identification number, the name and the added amount of the active substance shall be indicated on the label of the premixtures, if the following content of the active substance in complete feedingstuff with a moisture content of 12 % is exceeded: 25 mg/kg.

6.

The endotoxin content of the additive and its dusting potential shall ensure a maximal endotoxin exposure of 1 600 IU endotoxins/m3 airc.

7.

For users of the additive and premixture, feed business operators shall establish operational procedures and organisational measures to address potential by inhalation. Where those risks cannot be eliminated or reduced to a minimum by such procedures and measures, the additive and premixture shall be used with personal protective equipment.

26 October 2030

Characterisation of the active substance

L-isoleucine) produced by fermentation with Escherichia coli FERM ABP-10641

IUPAC name: (2S,3S)-2-amino-3-methylpentanoic acid

Chemical formula: C6H13NO2

CAS number: 73-32-5

Analytical method a

For the identification of L-isoleucine in the feed additive:

  • Food Chemical Codex ‘L-isoleucine monograph’

For the quantification of isoleucine in the feed additive:

  • ion exchange chromatography coupled with post-column derivatisation and optical detection (IEC-VIS/FLD) or

  • ion exchange chromatography coupled with post-column derivatisation and photometric detection (IEC-VIS)

For the quantification of isoleucine in premixtures:

  • ion-exchange chromatography coupled with post-column derivatisation and optical detection (IEC-VIS/FLD) or

  • ion exchange chromatography coupled with post-column derivatisation and photometric detection (IEC-VIS) – Regulation (EC) No 152/2009 (Annex III, F))

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.

Close

See additional information alongside the content

Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.

Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the EU Official Journal
  • lists of changes made by and/or affecting this legislation item
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

Timeline of Changes

This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.

The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.

For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.

Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources